ACLY and breast cancer: In the study of various tumors, including breast cancer, malignant mesothelioma, gastric cancer, salivary adenoid carcinoma, and noncoding RNA can affect the expression of lipid metabolism enzymes by directly binding to ACLY or by classical ceRNA mode, thus changing the malignant process of tumors.